C4 logo.jpg
C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
April 10, 2021 15:05 ET | C4 Therapeutics, Inc.
– CFT7455 Demonstrated High Cereblon Binding Affinity and Rapid, Deep IKZF1/3 Degradation Enabling Activity across a Panel of Multiple Myeloma Cell Lines Including IMiD-Resistant Models – –...
LOGO.jpg
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Athenex, Inc. Investors to Secure Counsel Before Important May 3 Deadline – ATNX
April 10, 2021 15:00 ET | The Rosen Law Firm PA
NEW YORK, April 10, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and...
KTMC-Logo_RGB.jpg
MPLN INVESTOR REMINDER:  Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against MultiPlan Corporation
April 10, 2021 14:28 ET | Kessler Topaz Meltzer & Check LLP
RADNOR, Pa., April 10, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces deadline in securities fraud class action lawsuit filed in the United States District...
IRTC Logo.png
iRhythm® Technologies Announces Conference Call to Discuss Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication
April 10, 2021 14:20 ET | iRhythm
SAN FRANCISCO, April 10, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today...
LOGO.jpg
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Ontrak, Inc. Investors to Secure Counsel Before Important May 3 Deadline – OTRK
April 10, 2021 14:00 ET | The Rosen Law Firm PA
NEW YORK, April 10, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ontrak, Inc. (NASDAQ: OTRK) between November 5, 2020 and...
Brisbane 8th Grader, Joshua Wood, Takes Home the Grand Prize in Lions Clubs International Peace Essay Contest
April 10, 2021 14:00 ET | Lions Clubs International
Oak Brook, April 10, 2021 (GLOBE NEWSWIRE) -- Joshua Wood, a 13-year-old boy from Brisbane, Australia, has an idea of what peace should mean to the world. Joshua brought that idea to life through a...
24 CHILDREN FROM AROUND THE WORLD NAMED AS FINALISTS IN LIONS CLUBS INTERNATIONAL’S PEACE POSTER CONTEST
April 10, 2021 14:00 ET | Lions Clubs International
Oak Brook, April 10, 2021 (GLOBE NEWSWIRE) -- Yue Zheng, a 13-year-old girl from Dalian, China, has a vision of what peace looks like. Zheng brought that vision to life through her art, earning her...
PMVP Logo.jpg
PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021
April 10, 2021 13:31 ET | PMV Pharmaceuticals, Inc.
PC14586 selectively stabilizes the p53 Y220C mutant and restores p53 activityRobust in vivo tumor regression observed with once daily oral dosingPharmacodynamic biomarkers of p53 activation developed...
Oncocyte_Logo_Horizontal_Main.jpg
Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
April 10, 2021 13:31 ET | Oncocyte Corporation
Achieved primary endpoint demonstrating significant correlation between DetermaIO and two-year overall survival rate to atezolizumab in metastatic bladder cancer DetermaIO identified additional...
zentalis_logo_large.jpg
Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session at AACR on ZN-c3, its WEE1 Inhibitor, in Patients with Advanced Solid Tumors
April 10, 2021 13:30 ET | ZENTALIS PHARMACEUTICALS
ZN-c3 demonstrated single agent activity, generating Exceptional Responses in a range of heavily pre-treated solid tumors ZN-c3 was safe and well-tolerated Identified recommended Phase 2 dose for...